Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoire Yalacta is a French healthcare company specializing in the development and manufacture of probiotic-based dietary supplements and lactic ferments. Founded in 1925, the company is a pioneer in the field of microbiology, originally inspired by the research of Nobel laureate Elie Metchnikoff regarding the benefits of lactic ferments. Yalacta's product portfolio focuses on digestive health, immune support, and mental well-being, with flagship products like Securil and Stabilium 200. The company utilizes specific strains of bacteria and natural active ingredients to address conditions such as irritable bowel syndrome and stress-related disorders. Now part of the Havea Group, Yalacta continues to distribute its specialized nutraceuticals through pharmacies and health stores globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoire Yalacta.